To view the PDF file, sign up for a MySharenet subscription.

Afrox Healthcare/Afrox/Bidco - Update as to timing for the Competition Tribunal

Release Date: 13/05/2004 14:49
Code(s): AFX AHH
Wrap Text

Afrox Healthcare/Afrox/Bidco - Update as to timing for the Competition Tribunal hearing Afrox Healthcare Limited Business Venture Investments (Incorporated in the No. 790 (Proprietary) Republic of South Africa) Limited (Registration number: (Incorporated in the 1985/001313/06) Republic of South Africa) Share code: AHH (Registration number: ISIN: ZAE000022059 2003/002733/07) ("Ahealth") ("Bidco") African Oxygen Limited (Incorporated in the Republic of South Africa) (Registration number 1927/000089/06) Share code: AFX ISIN: ZAE000030920 ("Afrox") Joint announcement from Ahealth, Bidco and Afrox as to timing for the Competition Tribunal hearing As announced on Tuesday 20 April 2004 by Afrox, the Competition Commission recommended, to the Competition Tribunal, that the merger of Bidco and Ahealth (the "merger") be approved subject to certain conditions. Bidco comprises a BEE consortium and Medi-Clinic Corporation Limited. The BEE consortium comprises Brimstone Investment Corporation Limited, Mvelaphanda Strategic Investments (Proprietary) Limited, and broad based empowerment groupings. In terms of an order issued by the Competition Tribunal, the hearing of the merger by the Competition Tribunal is scheduled to take place over the week of 19 - 23 July 2004. The approval by the Competition Tribunal is the only outstanding condition precedent for the acquisition by Bidco of all the shares in Ahealth. Johannesburg 13 May 2004 Sponsor to Afrox and Ahealth Nedbank Capital Date: 13/05/2004 02:49:03 PM Supplied by www.sharenet.co.za Produced by the JSE SENS Department

Share This Story